Clinical Trials for Philogen

Explore 18 clinical trials worldwide

Showing 1-18 of 18 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Philogen

Clinical Trials (18)

NCT07120984
A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma
PHASE2Not yet recruiting
52 participants
Started: Jan 30, 2026 · Completed: Jan 30, 2029
1 condition1 sponsor0 locations
NCT06640413
A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
PHASE1Not yet recruiting
56 participants
Started: May 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor4 locations
NCT06840548
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer
PHASE1Recruiting
20 participants
Started: Apr 16, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06840535
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
PHASE1Recruiting
20 participants
Started: Apr 8, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT06284590
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
PHASE2Recruiting
162 participants
Started: Jul 12, 2024 · Completed: Jul 31, 2028
2 conditions2 sponsors1 location
NCT06336291
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
PHASE2Recruiting
90 participants
Started: May 22, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor8 locations
NCT05622175
Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment
PHASE1Not yet recruiting
32 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT05329792
L19IL2/L19TNF in Skin Cancer Patients
PHASE2Recruiting
70 participants
Started: Mar 9, 2023 · Completed: Dec 31, 2024
7 conditions1 sponsor14 locations
NCT04573192
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PHASE1/PHASE2Recruiting
142 participants
Started: Feb 19, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor15 locations
NCT04443010
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
PHASE1/PHASE2Recruiting
226 participants
Started: Jan 20, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04362722
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
PHASE2Recruiting
40 participants
Started: Sep 2, 2020 · Completed: Sep 30, 2024
2 conditions1 sponsor11 locations
NCT04733183
Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma
PHASE2Active, not recruiting
98 participants
Started: Aug 28, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor23 locations
NCT04471987
Safety and Early Signs of Efficacy of IL12-L19L19.
PHASE1Recruiting
94 participants
Started: Jul 1, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor10 locations
NCT04032964
Dose Finding Study of L19TNF and Doxorubicin in Patients With STS
PHASE1Active, not recruiting
2 participants
Started: Sep 5, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03420014
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
PHASE2Recruiting
114 participants
Started: Dec 27, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT03567889
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients
PHASE3Recruiting
186 participants
Started: Sep 20, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor34 locations
NCT04650984
A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
PHASE3Recruiting
102 participants
Started: Nov 29, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor28 locations
NCT02938299
Neoadjuvant L19IL2/L19TNF- Pivotal Study
PHASE3Active, not recruiting
214 participants
Started: Jul 1, 2016 · Completed: Dec 31, 2028
1 condition1 sponsor22 locations